LEASES

3 Months Ended

Mar. 31, 2019

Leases [Abstract]

LEASES, LESSEE

LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles.The Company’s finance leases were not material as of March 31, 2019 and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets.

For the three months ended March 31, 2019, operating lease expense was $0.6 million, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the three months ended March 31, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities	$	444
ROU assets obtained in exchange for operating lease obligations	293

The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of March 31, 2019:

Weighted average remaining lease term	4.4 years
Weighted average discount rate	4.45	%

The following table presents the maturity of the Company's operating lease liabilities as of March 31, 2019 (in thousands):

Remainder of 2019	$	1,396
2020	1,611
2021	1,453
2022	1,320
2023	1,766
Total operating lease payments	7,546
Less: imputed interest	731
Total operating lease liabilities	$	6,815

Lessor Accounting

In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of March 31, 2019 (in thousands):

Year Ending December 31,
Remainder of 2019	$	2,409
2020	3,430
2021	3,364
2022	2,989
2023	2,147
Thereafter	1,501
	$	15,840

LEASES, LESSOR

LEASES

Lessee Accounting

The Company leases buildings, office equipment, and vehicles.The Company’s finance leases were not material as of March 31, 2019 and for the three-month period then ended. ROU assets arising from finance leases are included in Property and equipment, net in the accompanying Condensed Consolidated Balance Sheets. The current portion of the finance lease liabilities are included in Current portion of deferred revenue, and other and the non-current portion of the finance lease liabilities are included in Line of credit and other long term borrowings in the accompanying Condensed Consolidated Balance Sheets.

For the three months ended March 31, 2019, operating lease expense was $0.6 million, including immaterial variable lease costs.

Supplemental cash flow information related to the Company's operating leases for the three months ended March 31, 2019 was as follows (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities	$	444
ROU assets obtained in exchange for operating lease obligations	293

The following table presents the weighted average remaining lease term and weighted average discount rate related to the Company's operating leases as of March 31, 2019:

Weighted average remaining lease term	4.4 years
Weighted average discount rate	4.45	%

The following table presents the maturity of the Company's operating lease liabilities as of March 31, 2019 (in thousands):

Remainder of 2019	$	1,396
2020	1,611
2021	1,453
2022	1,320
2023	1,766
Total operating lease payments	7,546
Less: imputed interest	731
Total operating lease liabilities	$	6,815

Lessor Accounting

In our CCA segment, primarily related to our Point of Care laboratory products, the Company enters into sales-type leases as part of our subscription agreements. The following table presents the maturity of the Company's undiscounted lease receivables as of March 31, 2019 (in thousands):

Year Ending December 31,
Remainder of 2019	$	2,409
2020	3,430
2021	3,364
2022	2,989
2023	2,147
Thereafter	1,501
	$	15,840